High-Risk Clinicopathologic and Genomic Features of Recurrence in Stage I Lung Adenocarcinoma

C. N. Fick, E. G. Dunne,B. Mastrogiacomo,K. S. Tan, N. Toumbacaris,P. S. Adusumilli,G. Rocco,D. Molena,J. Huang, B. J. Park,M. J. Bott, V. R. Rusch,S. Sihag,J. M. Isbell,D. R. Jones

Journal of Thoracic Oncology（2023）

引用 0|浏览6

暂无评分

摘要

Surgical resection remains the standard of care for stage I non-small cell lung cancer. However, recurrence following surgery occurs in 10-30% of these patients and five-year disease-free survival is 50-80%. The aim of this study was to identify clinicopathologic and genomic features associated with recurrence following surgery for pathologic stage I lung adenocarcinoma (LUAD).

查看译文

关键词

recurrence,stage I,lung adenocarcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要